BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28052713)

  • 1. Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment.
    Grønningsæter IS; Tsykunova G; Lilleeng K; Ahmed AB; Bruserud Ø; Reikvam H
    Expert Rev Clin Immunol; 2017 Jun; 13(6):553-569. PubMed ID: 28052713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
    Sengsayadeth SM; Srivastava S; Jagasia M; Savani BN
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1479-87. PubMed ID: 22449611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.
    Abedin S; Yanik GA; Braun T; Pawarode A; Magenau J; Goldstein SC; Levine JE; Kitko CL; Couriel DR
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1127-31. PubMed ID: 25687798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Screening Spirometry for Early Diagnosis of Bronchiolitis Obliterans Syndrome in Children After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yoon JS; Chun YH; Lee JW; Chung NG; Cho B
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):e462-7. PubMed ID: 26334431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.
    Duque-Afonso J; Ihorst G; Waterhouse M; Zeiser R; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Marks R; Prasse A
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2277-2284. PubMed ID: 29964193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment.
    Bacigalupo A; Chien J; Barisione G; Pavletic S
    Semin Hematol; 2012 Jan; 49(1):15-24. PubMed ID: 22221781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation.
    Yoshihara S; Yanik G; Cooke KR; Mineishi S
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):749-59. PubMed ID: 17580252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
    Mohseni R; Mahdavi Sharif P; Behfar M; Modaresi MR; Shirzadi R; Mardani M; Jafari L; Jafari F; Nikfetrat Z; Hamidieh AA
    Stem Cell Res Ther; 2023 Sep; 14(1):256. PubMed ID: 37726865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal photopheresis for bronchiolitis obliterans syndrome after allogeneic stem cell transplant: An emerging therapeutic approach?
    Del Fante C; Perotti C
    Transfus Apher Sci; 2017 Feb; 56(1):17-19. PubMed ID: 28094112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience.
    Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC
    Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study.
    Chen S; Zhao K; Lin R; Wang S; Fan Z; Huang F; Chen X; Nie D; Du X; Guo Z; Lin D; Xuan L; Xu N; Sun J; Peng Xiang A; Liu Q
    EBioMedicine; 2019 Nov; 49():213-222. PubMed ID: 31668569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation.
    Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
    Chin Med J (Engl); 2013 Jul; 126(13):2489-94. PubMed ID: 23823823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchiolitis Obliterans Syndrome and Other Late Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.
    Bergeron A; Cheng GS
    Clin Chest Med; 2017 Dec; 38(4):607-621. PubMed ID: 29128013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Characterization Reveals That MMP-3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation.
    Liu X; Yue Z; Yu J; Daguindau E; Kushekhar K; Zhang Q; Ogata Y; Gafken PR; Inamoto Y; Gracon A; Wilkes DS; Hansen JA; Lee SJ; Chen JY; Paczesny S
    Am J Transplant; 2016 Aug; 16(8):2342-51. PubMed ID: 26887344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome.
    Kwok WC; Liang BM; Lui MMS; Tam TCC; Sim JPY; Tse EWC; Leung AYH; Kwong YL; Lie AKW; Ip MSM; Lam DCL
    Respirology; 2019 May; 24(5):459-466. PubMed ID: 30663178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.
    Au BK; Au MA; Chien JW
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1072-8. PubMed ID: 21126596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung Function Monitoring After Lung Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation.
    Sheshadri A; Sacks NC; Healey BE; Raza S; Boerner G; Huang HJ
    Clin Ther; 2022 May; 44(5):755-765.e6. PubMed ID: 35513911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.
    Chien JW; Duncan S; Williams KM; Pavletic SZ
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S106-14. PubMed ID: 19896545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuances in the interpretation and utility of donor-derived cell-free DNA in lung transplantation following allogeneic hematopoietic stem cell transplantation - Case report.
    Manickavel S; Glehn-Ponsirenas R; Gray J; Furuya Y; Fu D; Gulbahce N; Woodward R; Kaneku H; Castillo-Fernandez J; Salgado J; Pelaez A; Pipkin M; Machuca T; Sinha N
    Transpl Immunol; 2024 Jun; 84():102055. PubMed ID: 38744349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation.
    Nakane T; Nakamae H; Kamoi H; Koh H; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Ohta K; Terada Y; Koh KR; Yamane T; Hino M
    Bone Marrow Transplant; 2008 Jul; 42(1):43-9. PubMed ID: 18347569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.